{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:09:48Z","timestamp":1777853388244,"version":"3.51.4"},"reference-count":14,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the International Association of Physicians in AIDS Care"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:p>\n                    Objective: Detecting the prevalence of human cytomegalovirus (CMV) coinfection in HIV-infected individuals attending a tertiary care hospital in Delhi by using 3 laboratory tests namely pp65 antigenemia assay, CMV DNA polymerase chain reaction (PCR), and immunoglobulin M (IgM) enzyme-linked immunosorbent assay (ELISA) for anti-CMV antibody. Design: HIV seropositive patients with CD4 count \u2264100 cells\/mm\n                    <jats:sup>3<\/jats:sup>\n                    were included as cases and HIV-negative healthy individuals as controls. Blood samples were collected from all participants and 3 tests were performed. Methods: pp65 antigenemia assay and IgM ELISA were performed by commercially available kits; PCR was performed by an in-house nested PCR method. Results: In all, 7.1%, 5.7%, and 2.9% were positive for pp65 antigenemia, CMV DNA, and IgM antibody against CMV, respectively. On the basis of pp65 and\/or PCR positivity, it can be said that active CMV coinfection was present in 8.57% of the cases. Conclusion: In the post-antiretroviral therapy (ART) era, CMV coinfection in HIV-infected patients has significantly declined.\n                  <\/jats:p>","DOI":"10.1177\/1545109710366180","type":"journal-article","created":{"date-parts":[[2010,5,19]],"date-time":"2010-05-19T18:34:49Z","timestamp":1274294089000},"page":"94-97","source":"Crossref","is-referenced-by-count":6,"title":["Human Cytomegalovirus Infection Among Patients Living With AIDS in a Tertiary Level Hospital in India"],"prefix":"10.1177","volume":"9","author":[{"given":"Anita","family":"Chakravarti","sequence":"first","affiliation":[{"name":"Department of Microbiology, Maulana Azad Medical College, New Delhi, India,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayani","family":"Tewari","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Maulana Azad Medical College, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preena","family":"Bhalla","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Maulana Azad Medical College, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2010,5,19]]},"reference":[{"key":"atypb1","unstructured":"Mocarski ES, Shenk T., Pass RF Cytomegaloviruses. In: Knipe DM, Howley PM, Griffin DE , et al., eds. Field\u2019s Virology. 5th ed. Philidelphia: Lippincott, Williams and Wilkins; 2007: 2701-2772."},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1086\/497267"},{"key":"atypb3","first-page":"99","volume":"117","author":"Mujtaba S.","year":"2004","journal-title":"Indian J Med Res"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.34.10.2632-2634.1996"},{"key":"atypb5","unstructured":"Hirsch MS Cytomegalovirus and human herpesvirus types 6, 7 and 8. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison\u2019s Principles of Internal Medicine. 16th ed. New York: Mcgraw-Hill; 2004:1049-1052."},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200011100-00023"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200005260-00017"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1086\/504435"},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh396"},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.1086\/375843"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.5.2.204"},{"issue":"4","key":"atypb12","first-page":"203","volume":"87","author":"DeRodriguez CV","year":"1994","journal-title":"J R Soc Med"},{"issue":"1","key":"atypb13","first-page":"29","volume":"4","author":"Dieterich DT","year":"1991","journal-title":"J Acquir Immune Defic Syndr"},{"key":"atypb14","unstructured":"Hodinka RL Human cytomegalovirus. In: Murray PR, Baron EJ, Landry ML, Jorgensen JH, Pfaller MA, eds. Manual of Clinical Microbiology . 9th ed. Washington, DC: American Society of Microbiology; 2007:1549-1563."}],"container-title":["Journal of the International Association of Physicians in AIDS Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1545109710366180","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1545109710366180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:52:09Z","timestamp":1777503129000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1545109710366180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1177\/1545109710366180"],"URL":"https:\/\/doi.org\/10.1177\/1545109710366180","relation":{},"ISSN":["1545-1097"],"issn-type":[{"value":"1545-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}